SCHEMBL1737040

SCHEMBL1737040

Cc1c(C)n(CC2CC2)c2c(N3CCc4ccccc4C3)nc(Cl)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 1/20 0.40
PDE4A P27815 1/20 0.40
PDE4B Q07343 1/20 0.40
PDE4C Q08493 1/20 0.40
PDE4D Q08499 1/20 0.40
GRIN2D O15399 7/20 0.37
GRIN3B O60391 7/20 0.37
GRIN1 Q05586 7/20 0.37
GRIN2A Q12879 7/20 0.37
GRIN2B Q13224 7/20 0.37
GRIN2C Q14957 7/20 0.37
GRIN3A Q8TCU5 7/20 0.37
HPGD P15428 3/20 0.37
KDM4E B2RXH2 3/20 0.37
MAPT P10636 3/20 0.37
HTT P42858 3/20 0.37
CHRM1 P11229 3/20 0.37
ADRA1D P25100 3/20 0.37
ADRA1A P35348 3/20 0.37
ADRA1B P35368 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1735985 0.96 CHRM3 (0.39) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1736458 0.88 CHRM3 (0.40) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1737111 0.88 MEN1 (0.44) CHRM3PDE4APDE4BPDE4CPDE4D
Hydrochloric Acid SCHEMBL1735605 0.87 CHRM3 (0.40) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1738364 0.86 MAPT (0.40) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1736680 0.86 ALDH1A1 (0.42) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1736903 0.85 HPGD (0.40) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1737909 0.85 LMNA (0.39) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1737396 0.85 MDM2 (0.42) CHRM3PDE4APDE4BPDE4CPDE4D
SCHEMBL1737100 0.84 GRIN2D (0.41) CHRM3PDE4APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP claimed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US claimed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US claimed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US claimed
US-8188114-B2 Pyrrolo[2,3-C]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2012-05-29 US disclosed
EP-1784404-B1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORP (KR) 2011-11-16 EP disclosed
US-20110263306-A1 COMPUTER SYSTEM AND PROGRAM NAMCO BANDAI GAMES INC. (JP) 2011-10-27 US disclosed
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2010-03-18 US disclosed
US-7662832-B2 Pyrrolo[2,3-c]pyridine derivatives and processes for the preparation thereof YUHAN CORPORATION (KR) 2010-02-16 US disclosed
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF YUHAN CORPORATION (KR) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100069430-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H CHRM3 3715/4885PDE4A 663/4885PDE4B 633/4885
US-20070219230-A1 PYRROLO[2,3-C]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF PGA5, ATP6AP1, ATP6V1H CHRM3 3715/4885PDE4A 663/4885PDE4B 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.